Vertex Pharma (VRTX)
441.74
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 VERTEX PHARMACEUTICALS For: Jun 01 Filed by: Liu Joy
June 3, 2026 4:07 PM - SEC Filing
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
June 3, 2026 4:00 PM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: May 29 Filed by: Bozic Carmen
June 2, 2026 4:04 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy
June 1, 2026 2:14 PM - SEC Filing
Vertex gets FDA acceptance for IgA nephropathy drug application
June 1, 2026 8:01 AM - StreetInsider
Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
June 1, 2026 8:00 AM - BizWire
Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen
May 29, 2026 1:32 PM - SEC Filing
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 28, 2026 4:07 PM - StreetInsider
Truist Securities Assumes Vertex (VRTX) at Buy
May 27, 2026 1:02 AM - StreetInsider
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
May 20, 2026 3:10 PM - StreetInsider
JPMorgan Reinstates Vertex (VRTX) at Overweight
May 20, 2026 4:30 AM - StreetInsider
Form 4 VERTEX PHARMACEUTICALS For: May 15 Filed by: Bunnage Mark E.
May 19, 2026 4:05 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 15 Filed by: Bozic Carmen
May 19, 2026 4:04 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen
May 15, 2026 10:41 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Bunnage Mark E.
May 15, 2026 10:02 AM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 12 Filed by: Bozic Carmen
May 14, 2026 4:10 PM - SEC Filing
Form SCHEDULE 13G/A VERTEX PHARMACEUTICALS Filed by: Capital World Investors
May 14, 2026 1:56 PM - SEC Filing
Form SCHEDULE 13G/A VERTEX PHARMACEUTICALS Filed by: Capital Research Global Investors
May 14, 2026 10:20 AM - SEC Filing
Form S-8 POS VERTEX PHARMACEUTICALS
May 13, 2026 4:11 PM - SEC Filing
Form S-8 POS VERTEX PHARMACEUTICALS
May 13, 2026 4:10 PM - SEC Filing
Form S-8 POS VERTEX PHARMACEUTICALS
May 13, 2026 4:10 PM - SEC Filing
Form S-8 POS VERTEX PHARMACEUTICALS
May 13, 2026 4:10 PM - SEC Filing
Form S-8 POS VERTEX PHARMACEUTICALS
May 13, 2026 4:10 PM - SEC Filing
Form S-8 POS VERTEX PHARMACEUTICALS
May 13, 2026 4:10 PM - SEC Filing
Form S-8 POS VERTEX PHARMACEUTICALS
May 13, 2026 4:10 PM - SEC Filing
Form S-8 VERTEX PHARMACEUTICALS
May 13, 2026 4:08 PM - SEC Filing
Form 8-K VERTEX PHARMACEUTICALS For: May 13
May 13, 2026 4:03 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen
May 12, 2026 1:12 PM - SEC Filing
Vertex to Participate in Upcoming May Investor Conferences
May 11, 2026 4:00 PM - BizWire
BMO Capital Reiterates Market Perform Rating on Vertex (VRTX), 'positive steps'
May 8, 2026 8:59 AM - StreetInsider
Form 144 VERTEX PHARMACEUTICALS Filed by: Biller Jonathan
May 6, 2026 2:14 PM - SEC Filing
Vertex (VRTX) PT Raised to $615 at Barclays
May 6, 2026 7:04 AM - StreetInsider
Vertex secures German reimbursement for CASGEVY gene therapy
May 6, 2026 7:01 AM - StreetInsider
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
May 6, 2026 7:01 AM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Upadhyay Suketu
May 5, 2026 5:44 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Thornberry Nancy
May 5, 2026 5:38 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Schneider Jennifer
May 5, 2026 5:30 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: SACHS BRUCE I
May 5, 2026 5:25 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: MCKENZIE DIANA
May 5, 2026 5:18 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Liu Joy
May 5, 2026 5:11 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Lagarde Michel
May 5, 2026 5:07 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Garber Alan M
May 5, 2026 4:59 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: CARNEY LLOYD
May 5, 2026 4:54 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Bhatia Sangeeta N.
May 5, 2026 4:51 PM - SEC Filing
Form 10-Q VERTEX PHARMACEUTICALS For: Mar 31
May 5, 2026 4:10 PM - SEC Filing
Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX) Post Q1 Print
May 5, 2026 9:26 AM - StreetInsider
Vertex (VRTX) PT Raised to $616 at Morgan Stanley
May 5, 2026 8:01 AM - StreetInsider
Vertex (VRTX) PT Lowered to $436 at Canaccord
May 5, 2026 7:06 AM - StreetInsider
Vertex (VRTX) PT Raised to $543 at RBC Capital
May 5, 2026 6:36 AM - StreetInsider
Oppenheimer Reiterates Outperform Rating on Vertex (VRTX)
May 5, 2026 6:06 AM - StreetInsider
Vertex (VRTX) PT Lowered to $572 at Bernstein SocGen Group
May 5, 2026 5:59 AM - StreetInsider
Form 8-K VERTEX PHARMACEUTICALS For: May 04
May 4, 2026 4:06 PM - SEC Filing
Vertex Pharma (VRTX) Tops Q1 EPS by 14c, Misses on Revenue; Offers FY26 Revenue Guidance
May 4, 2026 4:03 PM - StreetInsider
Vertex Reports First Quarter 2026 Financial Results
May 4, 2026 4:01 PM - BizWire
Form 144 VERTEX PHARMACEUTICALS Filed by: Bhatia Sangeeta N.
May 4, 2026 10:18 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy
May 1, 2026 2:29 PM - SEC Filing
Form SCHEDULE 13G VERTEX PHARMACEUTICALS Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 2:30 PM - SEC Filing
Vortex Energy Announces Intent to Advance Next Phase of Technical Work at the Robinsons River Salt Project and Engages Lonquist
April 30, 2026 8:00 AM - Globe NewsWire
Vertex (VRTX) PT Lowered to $437 at Canaccord
April 30, 2026 6:35 AM - StreetInsider
Form DEFA14A VERTEX PHARMACEUTICALS
April 29, 2026 4:08 PM - SEC Filing
Form 8-K VERTEX PHARMACEUTICALS For: Apr 28
April 29, 2026 4:05 PM - SEC Filing
U.S. Biotech stocks: Q1 earnings previews
April 26, 2026 8:00 PM - StreetInsider
Vertex (VRTX) PT Lowered to $14 at BMO Capital
April 24, 2026 8:32 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
April 23, 2026 6:58 AM - StreetInsider
These are the best biotech stocks to own in 2026: BofA
April 19, 2026 10:00 AM - StreetInsider
Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: Upadhyay Suketu
April 17, 2026 4:21 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: SACHS BRUCE I
April 17, 2026 4:18 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: Garber Alan M
April 17, 2026 4:15 PM - SEC Filing
Zealand Pharma names Eric Rojas as VP of investor relations
April 14, 2026 10:01 AM - StreetInsider
Zealand Pharma names Eric Rojas as VP of investor relations
April 14, 2026 10:00 AM - StreetInsider
Bernstein on US Pharma and Biotech: Who might buy whom?
April 13, 2026 5:52 AM - StreetInsider
Vertex (VRTX) PT Lowered to $541 at RBC Capital
April 10, 2026 8:33 AM - StreetInsider
Vertex (VRTX) PT Raised to $612 at Morgan Stanley
April 10, 2026 8:16 AM - StreetInsider
Vertex (VRTX) PT Raised to $543 at RBC Capital
April 7, 2026 9:03 AM - StreetInsider
Halozyme licenses drug delivery technology to Vertex for $15 million
April 7, 2026 8:05 AM - StreetInsider
Vertex to Announce First Quarter 2026 Financial Results on May 4th
April 6, 2026 4:00 PM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: Apr 01 Filed by: Liu Joy
April 3, 2026 4:54 PM - SEC Filing
Form ARS VERTEX PHARMACEUTICALS For: Dec 31
April 2, 2026 4:08 PM - SEC Filing
Form DEFA14A VERTEX PHARMACEUTICALS
April 2, 2026 4:06 PM - SEC Filing
Form DEF 14A VERTEX PHARMACEUTICALS For: May 13
April 2, 2026 4:03 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy
April 1, 2026 1:02 PM - SEC Filing
Vertex gets FDA approval to expand ALYFTREK and TRIKAFTA to 95% of US CF patients
April 1, 2026 7:31 AM - StreetInsider
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
April 1, 2026 7:30 AM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: Mar 27 Filed by: Bozic Carmen
March 31, 2026 4:11 PM - SEC Filing
Form 8-K VERTEX PHARMACEUTICALS For: Mar 31
March 31, 2026 4:04 PM - SEC Filing
BMO Capital on Vertex (VRTX): 'Ivacaftor Related Label Updates Unlikely to Impact CF Franchise Strength'
March 30, 2026 8:26 AM - StreetInsider
BMO Capital on Vertex (VRTX): label updates weigh on shares, but risk is limited
March 27, 2026 3:37 PM - StreetInsider
Form SCHEDULE 13G/A VERTEX PHARMACEUTICALS Filed by: VANGUARD GROUP INC
March 27, 2026 1:55 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen
March 27, 2026 10:32 AM - SEC Filing
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
March 21, 2026 1:55 PM - StreetInsider
RBC Capital on Vertex (VRTX): 'Recent Weakness Creates Buying Opportunity'
March 19, 2026 8:55 AM - StreetInsider
Vertex (VRTX) PT Raised to $520 at Argus
March 19, 2026 5:27 AM - StreetInsider
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
March 18, 2026 9:21 AM - StreetInsider
Maxim Group Upgrades Vertex (VRTX) to Buy
March 18, 2026 7:59 AM - StreetInsider
Form 4 VERTEX PHARMACEUTICALS For: Mar 13 Filed by: Bozic Carmen
March 17, 2026 4:06 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Mar 11 Filed by: McKechnie Duncan
March 13, 2026 4:12 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen
March 13, 2026 11:38 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: McKechnie Duncan
March 11, 2026 9:45 AM - SEC Filing
Vertex (VRTX) PT Raised to $525 at Truist Securities
March 10, 2026 9:51 AM - StreetInsider
Stifel Reiterates Hold Rating on Vertex (VRTX)
March 10, 2026 9:33 AM - StreetInsider
Vertex (VRTX) PT Raised to $596 at Morgan Stanley
March 10, 2026 8:47 AM - StreetInsider
Vertex (VRTX) PT Raised to $641 at H.C. Wainwright
March 10, 2026 8:27 AM - StreetInsider
Bernstein: 'We continue to recommend Vertex (VRTX) and see no reason to take profits'
March 10, 2026 8:02 AM - StreetInsider
Jefferies Starts Vertex (VRTX) at Buy
March 10, 2026 5:37 AM - StreetInsider
Jefferies Starts Gilead Sciences (GILD) at Buy
March 10, 2026 5:37 AM - StreetInsider
Jefferies Starts Amgen (AMGN) at Hold
March 10, 2026 5:37 AM - StreetInsider
Vertex (VRTX) PT Raised to $600 at Oppenheimer
March 10, 2026 5:09 AM - StreetInsider
Vertex (VRTX) PT Raised to $585 at Citi
March 10, 2026 4:56 AM - StreetInsider
Wolfe Research Reiterates Outperform Rating on Vertex (VRTX) following Ph3
March 9, 2026 5:35 PM - StreetInsider
BMO Capital Reiterates Outperform Rating on Vertex (VRTX) amid interim RAINIER data
March 9, 2026 5:07 PM - StreetInsider
After-hours movers: Hewlett Packard Enterprise, Yext, Vertex Pharma
March 9, 2026 4:44 PM - StreetInsider
Vertex reports positive phase 3 results for IgA nephropathy drug
March 9, 2026 4:02 PM - StreetInsider
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
March 9, 2026 4:02 PM - BizWire
Full Article List
